SER vs TER · rev $56.0K vs P/E 76, rev $2.82B
Serina Therapeutics Inc (SER) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
SER currently screens at market cap $29.7M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the SER and TER stock pages for the full models.
Not investment advice.